Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis.

Biological sciences Cancer Neuroscience Omics

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
17 Feb 2023
Historique:
received: 26 07 2022
revised: 23 11 2022
accepted: 26 01 2023
entrez: 23 2 2023
pubmed: 24 2 2023
medline: 24 2 2023
Statut: epublish

Résumé

Malignant peripheral nerve sheath tumors (MPNSTs) are soft-tissue sarcomas of the peripheral nervous system that develop either sporadically or in the context of neurofibromatosis type 1 (NF1). MPNST diagnosis can be challenging and treatment outcomes are poor. We present here a resource consisting of the genomic characterization of 9 widely used human MPNST cell lines for their use in translational research. NF1-related cell lines recapitulated primary MPNST copy number profiles, exhibited

Identifiants

pubmed: 36818284
doi: 10.1016/j.isci.2023.106096
pii: S2589-0042(23)00173-6
pmc: PMC9929861
doi:

Types de publication

Journal Article

Langues

eng

Pagination

106096

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Am J Surg Pathol. 2016 Jul;40(7):896-908
pubmed: 27158754
Nat Commun. 2021 Jan 21;12(1):498
pubmed: 33479225
Adv Anat Pathol. 2015 Jul;22(4):227-41
pubmed: 26050260
Carcinogenesis. 2006 Mar;27(3):664-71
pubmed: 16357008
Sci Rep. 2017 Nov 8;7(1):14992
pubmed: 29118384
Clin Cancer Res. 2008 Oct 15;14(20):6618-24
pubmed: 18927303
Genes Chromosomes Cancer. 1994 Aug;10(4):250-5
pubmed: 7522538
Genes Chromosomes Cancer. 2017 May;56(5):421-426
pubmed: 28124441
In Vitro Cell Dev Biol Anim. 1998 Jan;34(1):1-8
pubmed: 9542623
J Clin Invest. 2013 Jan;123(1):340-7
pubmed: 23221341
Lab Invest. 2007 Nov;87(11):1092-102
pubmed: 17876295
Cancer. 2006 Sep 1;107(5):1065-74
pubmed: 16881077
Cancer Res. 2006 Mar 1;66(5):2584-91
pubmed: 16510576
Methods Mol Biol. 2011;731:35-43
pubmed: 21516396
Genes Chromosomes Cancer. 1999 Dec;26(4):376-80
pubmed: 10534774
J Clin Oncol. 2016 Jun 10;34(17):1978-86
pubmed: 26926675
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
Int J Clin Exp Pathol. 2019 May 01;12(5):1738-1744
pubmed: 31933992
Cancer. 2008 Nov 15;113(10):2770-8
pubmed: 18823042
Am J Clin Oncol. 2011 Aug;34(4):417-21
pubmed: 20838322
Bioinformatics. 2017 Oct 01;33(19):3088-3090
pubmed: 28575171
Hum Mutat. 2013 Jan;34(1):57-65
pubmed: 23033316
Sci Transl Med. 2016 Aug 31;8(354):354re3
pubmed: 27582061
Neuropathol Appl Neurobiol. 2018 Feb;44(2):163-171
pubmed: 28295484
Acta Neuropathol. 2012 Mar;123(3):295-319
pubmed: 22327363
Cancer. 1986 May 15;57(10):2006-21
pubmed: 3082508
Hum Pathol. 2017 Sep;67:1-10
pubmed: 28551330
Neuro Oncol. 2018 May 18;20(6):818-825
pubmed: 29409029
Neuro Oncol. 2014 Mar;16(3):466-7
pubmed: 24366910
Nat Rev Cancer. 2011 Jul 14;11(8):541-57
pubmed: 21753790
EMBO Mol Med. 2015 Mar 25;7(5):608-27
pubmed: 25810463
Oncotarget. 2016 Jun 14;7(24):35753-35767
pubmed: 26840085
Sarcoma. 2009;2009:756395
pubmed: 19360115
Cell. 2017 Nov 2;171(4):950-965.e28
pubmed: 29100075
Mod Pathol. 2021 Feb;34(2):396-407
pubmed: 32860002
EMBO Mol Med. 2009 Jul;1(4):236-48
pubmed: 20049725
Genome Biol. 2014 Jun 26;15(6):R84
pubmed: 24970577
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
PLoS Comput Biol. 2016 Apr 21;12(4):e1004873
pubmed: 27100738
Nat Methods. 2010 Aug;7(8):575-6
pubmed: 20676075
Am J Hum Genet. 2017 Feb 2;100(2):267-280
pubmed: 28132688
Genome Res. 2009 Sep;19(9):1639-45
pubmed: 19541911
Am J Dermatopathol. 2010 May;32(3):262-266
pubmed: 20098296
Sci Rep. 2020 Oct 26;10(1):18217
pubmed: 33106540
Neurosurgery. 2021 Feb 16;88(3):443-456
pubmed: 33588442
Nat Genet. 2014 Nov;46(11):1227-32
pubmed: 25240281
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
PLoS One. 2010 Jul 29;5(7):e11858
pubmed: 20686603
Am J Dermatopathol. 2013 Jul;35(5):576-81
pubmed: 23291581
Am J Surg Pathol. 2015 Oct;39(10):1357-62
pubmed: 26076063
Genes Chromosomes Cancer. 2011 Dec;50(12):1021-32
pubmed: 21987445
Hum Genet. 2021 Aug;140(8):1241-1252
pubmed: 34059954
Int J Oncol. 2000 Aug;17(2):347-52
pubmed: 10891546
Nucleic Acids Res. 2011 Sep 1;39(17):e118
pubmed: 21727090
J Cell Physiol. 1998 Nov;177(2):334-42
pubmed: 9766530
J Med Genet. 2002 May;39(5):311-4
pubmed: 12011145
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
N Engl J Med. 1991 Feb 14;324(7):436-42
pubmed: 1988828
Int J Radiat Biol. 1993 Feb;63(2):191-8
pubmed: 8094415
Actas Dermosifiliogr. 2022 Jan;113(1):47-57
pubmed: 35249710
Nat Methods. 2018 Aug;15(8):591-594
pubmed: 30013048
Sarcoma. 2017;2017:7429697
pubmed: 28592921
Cancer Res. 2002 Mar 1;62(5):1573-7
pubmed: 11894862
J Natl Compr Canc Netw. 2018 Aug;16(8):967-974
pubmed: 30099373
Nucleic Acids Res. 2014 Jan;42(Database issue):D986-92
pubmed: 24174537
Virchows Arch. 1998 Nov;433(5):435-41
pubmed: 9849858
Nat Methods. 2015 Oct;12(10):966-8
pubmed: 26258291
Genome Biol. 2009;10(11):R128
pubmed: 19903341
J Surg Oncol. 2008 Mar 15;97(4):340-9
pubmed: 18286466
Orphanet J Rare Dis. 2017 May 23;12(1):97
pubmed: 28535796
Neurooncol Adv. 2019 Nov 28;2(Suppl 1):i50-i61
pubmed: 32642732
Nature. 2017 May 11;545(7653):175-180
pubmed: 28467829
Histopathology. 2013 Feb;62(3):499-504
pubmed: 23190154
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Eur J Cancer. 2020 Sep;137:175-182
pubmed: 32781392
Neurobiol Dis. 2004 Jun;16(1):85-91
pubmed: 15207265

Auteurs

Miriam Magallón-Lorenz (M)

Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.

Ernest Terribas (E)

Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.

Sara Ortega-Bertran (S)

Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL), L'Hospitalet de Llobregat, 08098 Barcelona, Spain.
Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

Edgar Creus-Bachiller (E)

Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL), L'Hospitalet de Llobregat, 08098 Barcelona, Spain.
Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Marco Fernández (M)

Cytometry Core Facility, Germans Trias & Pujol Research Institute (IGTP), Badalona, Barcelona, Spain.

Gerard Requena (G)

Cytometry Core Facility, Germans Trias & Pujol Research Institute (IGTP), Badalona, Barcelona, Spain.

Inma Rosas (I)

Clinical Genomics Research Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.
Clinical Genomics Unit, Clinical Genetics Service, Northern Metropolitan Clinical Laboratory, Germans Trias i Pujol University Hospital (HGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.

Helena Mazuelas (H)

Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.

Itziar Uriarte-Arrazola (I)

Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.

Alex Negro (A)

Clinical Genomics Research Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.
Clinical Genomics Unit, Clinical Genetics Service, Northern Metropolitan Clinical Laboratory, Germans Trias i Pujol University Hospital (HGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.

Tereza Lausová (T)

Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.

Elisabeth Castellanos (E)

Clinical Genomics Research Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.
Clinical Genomics Unit, Clinical Genetics Service, Northern Metropolitan Clinical Laboratory, Germans Trias i Pujol University Hospital (HGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.

Ignacio Blanco (I)

Clinical Genomics Research Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.
Genetic Counseling Unit, Clinical Genetics Service, Northern Metropolitan Clinical Laboratory, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

George DeVries (G)

Hines VA Hospital, Hines, IL 60141, USA.

Hiroyuki Kawashima (H)

Division of Orthopedic Surgery, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medical and Dental Sciences, Palliative Care Team, Niigata University Medical and Dental Hospital, Niigata, Japan.

Eric Legius (E)

Department of Human Genetics, KU Leuven, Leuven, Belgium.

Hilde Brems (H)

Department of Human Genetics, KU Leuven, Leuven, Belgium.

Viktor Mautner (V)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Lan Kluwe (L)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Nancy Ratner (N)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Margaret Wallace (M)

Department of Molecular Genetics & Microbiology, and UF Health Cancer Center, University of Florida College of Medicine, Gainesville, FL, USA.

Juana Fernández-Rodriguez (J)

Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL), L'Hospitalet de Llobregat, 08098 Barcelona, Spain.
Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Conxi Lázaro (C)

Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL), L'Hospitalet de Llobregat, 08098 Barcelona, Spain.
Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Jonathan A Fletcher (JA)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA 02115, USA.

David Reuss (D)

Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.

Meritxell Carrió (M)

Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.

Bernat Gel (B)

Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.
Departament de Fonaments Clínics, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), 08036 Barcelona, Spain.

Eduard Serra (E)

Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Classifications MeSH